The vaccine being developed by CNBG's Beijing unit was the first in China to be approved for general public use in late December.It was not immediately clear which CNBG vaccine Yang was referring to in his comments about clinical trials on children and teenagers. Sinopharm and CNBG were not immediately available for comment.The CNBG vaccine approved for general public use was 79.
Having managed to largely contain the coronavirus pandemic after it hit the economic powerhouse last year, China is now grappling with clusters of rising cases, which has prompted the government to impose restrictions and lockdowns in certain regions.China's vaccination programme, which started in July for emergency use, was widened to include more priority groups in December but does not yet cover people younger than 18 and older than 59 due to insufficient clinical data.
Sinovac's COVID-19 vaccine candidate and a shot from CanSino Biologics are also being tested on children and teenagers. Western vaccine developers including Pfizer and Moderna have also included children as young as 12 years in their clinical trials.
Oh , i love it .....
Wonderful news
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.